Schulungsreihe pDL Inhalativa: Spiromax

This video explains the correct handling of the Spiromax dry powder inhaler and its special features for healthcare professionals. It demonstrates, in particular, how to instruct patients. To raise awareness of potential and especially relevant sources of error when inhaling with this device, these are presented within the context of patient training. A simplified procedure for providing the service is shown. For the recommended procedure, please refer to the information on the pDL Campus website under pDL Inhalativa. The video was produced with the utmost care to ensure that the handling is demonstrated correctly. Adapt the instructions to the individual knowledge and needs of your patients. . ... 0:00 Intro 0:47 Introduction 1:12 Demonstration of the correct inhalation technique 2:23 Practicing inhalation with typical user errors 3:52 Key points of the consultation 4:31 Additional consultation notes 6:40 Outro Device type: Dry powder inhaler with reservoir Mechanism: • Drug doses are prepared by opening the mouthpiece cap • Aerosol generation through a combination of device resistance and the shear forces of forced inspiration Inhalation technique: • Smooth, forceful inhalation • The device's resistance necessitates a moderate breath strength Key messages of the consultation: • The core of the breathing maneuver is smooth, forceful inhalation followed by a 5-10 second pause • Sensitize patients who regularly use both dry powder inhalers and metered-dose inhalers to the different inhalation maneuver • Risk of confusion with metered-dose inhalers • Avoid covering the air vents during inhalation. Available preparations: The Spiromax is available on the German market as DuoResp Spiromax: • DuoResp Spiromax – Budesonide + Formoterol (glucocorticoid + long-acting β2-sympathomimetic) The active ingredients in Spiromax are for long-term therapy and not suitable for the acute treatment of an attack of shortness of breath. Further links: Materials and information on the administration of pDL inhalers: https://www.abda.de/pharmazeutische-d... pDL Campus live! continuing education series: https://www.pdlcampus-live.de/pdl/liv... Sources: German Respiratory Society: Inhalation with the Spiromax; Last accessed on April 21, 2026 at: https://www.atemwegsliga.de/spiromax.... Teva Pharma B.V. (as of January 2025): Patient Information Leaflet: Information for patients; DuoResp Spiromax 160 micrograms/4.5 micrograms inhalation powder, last accessed on April 21, 2026 at: https://www.apotheken-umschau.de/medi... Jeaschke, Robert/Spindler, Thomas: Inhalativa. Stuttgart: Deutscher Apotheker Verlag 2023. Kircher W. Correctly Using Dosage Forms: Proper Use and Storage of Medicines. 4th, completely revised edition. Stuttgart: Deutscher Apotheker Verlag 2016. © BAK – German Federal Chamber of Pharmacists Status: April 2026